Erythrasma

L12_ERYTHRASMA

erythrasma: a skin disease that causes brown, scaly skin patches. It is caused by the Gram-positive bacterium Corynebacterium minutissimum. It is prevalent among diabetics and the obese, and in warm climates; it is worsened by wearing occlusive clothing.

Suggest a new description

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — L08.1 Hospital discharge: ICD-9 — 390 Cause of death: ICD-10 — L08.1 Cause of death: ICD-9 — 390 2 out of 7 registries used, show all original rules.	77
4. Check minimum number of events None	77
5. Include endpoints None	77
6. Filter based on genotype QC (FinnGen only)	77

Control definitions (FinnGen only)

Control exclude: L12_INFECT_SKIN

Extra metadata

Level in the ICD hierarchy: 4
First used in FinnGen datafreeze: DF4
Parent code in ICD-10: L08
Name in latin: Erythrasma

NAME	L12_ERYTHRASMA
CONTROL_EXCLUDE	L12_INFECT_SKIN
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	L081
HD_ICD_9	390
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	L081
COD_ICD_9	390
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Erythrasma based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	476	191	281
Only index persons	408	160	248
Unadjusted period prevalence (%)
Whole population	0.01	0.01	0.01
Only index persons	0.01	0.01	0.01
Median age at first event (years)
Whole population	50.66	50.13	50.99
Only index persons	47.94	47.52	48.22

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	77	27	50
Unadjusted period prevalence (%)	0.02	0.01	0.02
Median age at first event (years)	52.13	53.47	51.40

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

No data

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
70: Matched controls
708

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

L08.1

ICD-10 Finland

Erythrasma

+∞

81.9

L30.9

ICD-10 Finland

Dermatitis, unspecified

5.8

8.9

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

10.3

8.7

3900A

ICD-9 Finland

Rheumatic fever without mention of heart involvement[FEBRIS RHEUMATICA, MORBO CORDIS NON INDICATO]

+∞

7.4

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(40768443) Skin Pathology biopsy report

5.68

5.45

1.1

—

(3022096) Basophils/100 leukocytes in Blood

244

2.76

4.49

7.3

5.8

0.7

0.08

232

(3006504) Eosinophils/100 leukocytes in Blood

254

2.74

4.42

7.8

5.8

2.8

0.02

241

(3019069) Monocytes/100 leukocytes in Blood

257

2.69

4.28

8.5

6.1

9.0

8.6

0.46

245

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

232

2.67

4.24

10.5

6.3

1.2

mmol/l

0.63

202

(3001604) Monocytes [#/volume] in Blood

276

2.69

4.22

7.4

5.7

0.6

e9/l

0.71

242

(3013650) Neutrophils [#/volume] in Blood by Automated count

309

2.65

3.98

11.6

8.3

3.8

4.1

e9/l

0.43

275

(3007853) Bacteria identified in Skin by Aerobe culture

3.24

3.90

1.3

1.5

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

9.48

3.86

1.1

1.0

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

9.48

3.86

1.1

1.0

—

(42870588) Differential panel, method unspecified - Blood

177

2.53

3.70

5.3

6.0

—

(3023368) Bacteria identified in Blood by Culture

126

2.62

3.57

4.1

3.9

—

(36304419) Bacteria [Presence] in Urine

135

2.41

3.04

5.1

2.1

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

2.56

2.93

1.1

1.3

1.9

15.3

u/ml

—

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

185

2.26

2.91

5.7

2.4

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

189

2.20

2.73

1.9

1.8

96.8

89.6

pmol/l

0.36

110

(3012544) pH of Venous blood

3.05

2.69

4.9

4.2

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

2.73

2.54

1.6

1.7

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

114

2.31

2.54

1.2

2.0

1.2

mg/l

0.07

(3037467) Urinalysis macro (dipstick) panel - Urine

359

2.15

2.52

6.0

3.7

—

(3007164) IgA [Mass/volume] in Serum or Plasma

101

2.33

2.44

1.6

1.4

3.7

2.5

g/l

0.97

(3018418) pH of Serum or Plasma

140

2.17

2.39

7.2

3.2

7.4

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

189

2.08

2.38

2.9

3.3

28.1

82.3

ng/l

1.12

127

(40760892) CBC W Ordered Manual Differential panel - Blood

126

2.18

2.31

7.7

4.4

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

112

2.21

2.25

1.5

1.3

2.3

1.4

u/ml

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

2.54

2.11

1.5

1.7

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

2.46

2.10

4.6

2.1

2.5

2.3

g/l

0.35

(3000991) Gas panel - Venous blood

2.80

2.01

7.4

4.4

—

(3004588) Protein electrophoresis panel - Serum or Plasma

3.19

2.00

1.6

1.8

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

2.15

1.91

1.1

1.4

41.6

47.6

iu/ml

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

104

2.10

1.89

1.5

1.8

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

2.20

1.86

1.6

1.9

—

(3032080) INR in Blood by Coagulation assay

206

1.85

1.77

11.9

8.8

1.1

1.2

inr

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

2.12

1.71

1.6

1.8

—

(40768797) Stomach Pathology biopsy report

2.19

1.67

1.1

1.2

—

(40758558) Short blood count panel - Blood

133

1.92

1.66

5.0

6.2

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

2.75

1.55

2.6

2.3

43.3

39.4

u/l

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

3.49

1.55

1.8

1.9

0.2

0.3

g/l

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

3.01

1.54

1.3

1.1

—

(3044640) Blood type and Crossmatch panel - Blood

162

1.81

1.52

2.1

—

(3022948) Iron [Moles/volume] in Serum or Plasma

2.09

1.51

4.7

2.2

13.5

16.0

umol/l

0.44

(3026008) Bacteria identified in Urine by Culture

113

1.91

1.49

4.8

2.8

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

3.27

1.46

2.4

2.3

48.8

132.3

ug/min

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

2.74

1.39

1.2

1.0

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

2.74

1.39

10.3

5.2

25.4

24.9

mmol/l

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

3.07

1.38

1.8

1.1

1.2

g/l

—

(3002385) Erythrocyte distribution width [Ratio]

475

1.80

1.38

23.2

14.4

13.8

13.7

0.24

462

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

1.95

1.35

5.0

2.0

0.6

0.7

e6/l

—

(1761482) Bacteria [#/volume] in Urine by Culture

2.74

1.23

6.6

5.5

—

(3020682) Albumin/Creatinine [Ratio] in Urine

154

1.71

1.23

6.8

4.0

19.9

8.9

mg/mmol

0.33

103

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

1.92

1.23

5.1

2.1

0.4

2.3

e6/l

—

(3000330) Specific gravity of Urine by Test strip

2.42

1.21

6.7

4.0

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

121

1.76

1.20

1.6

2.0

—

(3020961) Endomysium IgA Ab [Titer] in Serum

2.47

1.11

1.2

1.1

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

2.23

1.09

4.4

4.6

124.7

130.8

g/l

—

(3012516) Albumin [Mass/volume] in Urine

142

1.66

1.07

4.6

3.4

171.8

65.4

mg/l

0.34

(3015736) pH of Urine

205

1.58

1.05

4.9

2.9

—

(40768804) Tissue Pathology biopsy report

217

1.54

0.98

2.0

—

(3021589) Normoblasts [#/volume] in Blood

237

1.52

0.94

12.2

7.9

0.0

e9/l

0.00

186

(3021879) Hepatitis B virus core Ab [Presence] in Serum

1.90

0.93

1.4

1.7

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

0.00

0.81

0.0

1.6

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

391

1.45

0.78

4.2

3.6

14.4

14.5

pmol/l

0.15

362

(3019832) Treponema pallidum Ab [Presence] in Serum

1.72

0.77

1.9

1.8

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

2.07

0.74

3.6

2.8

0.7

0.8

—

(36660697) Celiac disease serology panel - Serum

1.78

0.72

1.3

1.2

—

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

1.99

0.72

11.2

3.6

50.0

49.3

—

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

1.99

0.72

3.6

2.7

1.6

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

1.99

0.72

1.2

1.4

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

1.99

0.72

1.0

1.4

—

(3017732) Neutrophils [#/volume] in Blood

1.73

0.70

5.0

2.4

3.6

4.1

e9/l

—

(3035350) Ketones [Presence] in Urine by Test strip

268

1.41

0.70

5.4

3.0

0.0

estimate

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

1.91

0.70

8.2

7.8

—

(3041096) Erythrocytes [Presence] in Urine by Automated

157

1.47

0.69

5.4

2.8

—

(3021601) Nitrite [Presence] in Urine by Test strip

269

1.40

0.69

7.2

4.4

0.0

estimate

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

113

1.53

0.68

1.3

1.7

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

122

1.51

0.67

1.9

2.1

—

(3000494) Fungus identified in Specimen by Culture

1.62

0.67

1.4

1.3

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

1.84

0.67

8.8

4.5

23.7

24.2

mmol/l

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

1.84

0.67

2.2

1.8

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

233

1.40

0.65

4.9

3.7

—

(3042936) Bacteria identified in Isolate by Culture

1.59

0.64

1.9

1.7

—

(3044889) 12 lead EKG panel

380

1.38

0.63

3.7

3.6

—

(3016502) Oxygen saturation in Arterial blood

1.60

0.62

7.1

6.4

94.8

96.4

—

(3009261) Glucose [Presence] in Urine by Test strip

273

1.37

0.62

5.4

3.1

0.0

estimate

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

1.57

0.61

1.8

1.6

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

1.72

0.58

1.8

1.6

—

(40761536) Microorganisms panel - Urine sediment

1.63

0.56

8.3

2.9

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

1.49

0.55

2.1

2.0

—

(3022145) Colonoscopy Study observation

1.40

0.42

1.6

1.4

—

(3025941) Bacteria identified in Stool by Culture

1.55

0.42

1.4

1.3

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

0.00

0.41

0.0

1.8

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

0.00

0.41

0.0

4.5

—

193.5

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

0.00

0.39

0.0

4.2

—

84.9

—

(3019225) pH of Specimen

1.39

0.35

4.2

4.8

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

216

1.23

0.31

5.2

3.1

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

495

1.23

0.30

5.8

4.2

2.0

1.8

mu/l

0.45

460

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

207

1.23

0.30

3.3

3.9

21.4

20.3

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

1.24

0.28

1.1

1.5

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

582

1.24

0.25

22.4

13.0

139.9

139.7

mmol/l

0.26

568

(3003694) ABO and Rh group [Type] in Blood

153

1.23

0.25

1.3

1.4

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

1.38

0.24

2.8

4.4

—

(3019060) Gas panel - Arterial blood

1.34

0.24

3.6

5.4

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

0.00

0.21

0.0

1.1

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

0.00

0.21

0.0

1.5

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

0.00

0.21

0.0

3.0

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

0.00

0.21

0.0

3.8

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

0.00

0.21

0.0

4.2

—

2.5

—

(3003181) Sodium [Moles/volume] in Urine

0.00

0.21

0.0

1.5

—

78.3

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

575

1.21

0.21

20.9

12.1

21.1

23.4

mg/l

0.27

441

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

1.30

0.21

1.5

1.6

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

0.00

0.21

0.0

1.3

—

(4094501)

0.00

0.20

0.0

1.4

—

(3002256) Pathology report gross observation

1.21

0.18

1.6

1.2

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

624

1.16

0.12

23.9

13.5

88.3

80.1

umol/l

0.67

624

(1761868) Lipid panel - Serum or Plasma

223

1.11

0.11

5.0

2.6

—

(3013512) EKG study

156

1.12

0.09

5.6

3.7

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

1.08

0.09

11.2

6.0

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

594

0.90

0.08

5.9

4.5

2.8

mmol/l

0.14

555

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

546

1.10

0.08

16.9

10.3

81.2

85.0

ml/min/173m2

0.44

438

(3035941) MCH [Entitic mass]

654

1.07

0.01

30.6

17.3

30.3

30.4

0.16

647

(40761511) CBC panel - Blood by Automated count

618

1.02

0.00

19.3

11.3

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

148

1.02

0.00

3.1

2.7

0.4

0.7

ug/l

—

104

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

405

0.97

0.00

2.6

3.5

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

555

0.97

0.00

6.2

4.3

6.2

5.9

mmol/l

0.72

516

(3024731) MCV [Entitic volume]

655

1.06

0.00

30.7

17.3

90.6

90.8

0.10

648

(3000963) Hemoglobin [Mass/volume] in Blood

655

1.06

0.00

30.7

17.4

138.3

140.5

g/l

0.57

649

(3026361) Erythrocytes [#/volume] in Blood

655

1.06

0.00

30.7

17.3

4.6

e12/l

0.27

638

(3029937) Albumin [Presence] in Urine by Test strip

139

1.01

0.00

5.1

3.2

0.0

estimate

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

119

1.01

0.00

4.8

3.0

—

(3011985) Renin [Units/volume] in Plasma

0.00

0.0

1.1

—

13.5

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

0.00

0.0

5.1

—

23.4

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

0.00

0.0

2.3

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

1.00

0.00

2.1

2.4

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

2.0

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

2.0

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

0.00

0.0

1.7

—

(3000093) Morphology [Interpretation] in Blood Narrative

0.00

0.0

1.4

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

2.0

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

0.00

0.0

2.3

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

0.00

0.0

2.5

—

(3019897) Erythrocyte distribution width [Ratio] by Automated count

0.00

0.0

1.4

—

12.8

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

0.00

0.0

1.4

—

(3009542) Hematocrit [Volume Fraction] of Blood

550

1.00

0.00

20.5

12.1

41.1

41.0

0.04

440

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

0.95

0.00

1.7

2.2

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

0.00

0.0

1.0

—

(3035933) Granulocytes/100 leukocytes in Blood

0.00

0.0

1.0

—

(4035726)

0.89

0.00

1.4

1.3

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

0.00

0.0

1.0

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

0.00

0.0

1.7

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.9

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

0.00

0.0

1.8

—

0.8

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

0.00

0.0

2.0

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

0.00

0.0

1.0

—

(3025130) Human papilloma virus identified in Specimen

0.00

0.0

1.7

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

0.00

0.0

1.0

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

0.00

0.0

2.3

—

(40768441) Liver Pathology biopsy report

0.00

0.0

1.0

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

0.00

0.0

1.1

—

68.7

—

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

0.00

0.0

1.3

—

21.6

—

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

0.00

0.0

1.2

—

(40768793) Breast Pathology biopsy report

0.00

0.0

1.3

—

(3000012) Reticulocyte production index

0.00

0.0

1.4

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

0.00

0.0

1.2

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

0.00

0.0

2.5

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

0.00

0.0

2.8

—

(3000492) Spirometry study

0.93

0.00

1.3

—

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

0.00

0.0

1.4

—

5.4

—

(3016038) Potassium [Moles/volume] in Urine

0.00

0.0

1.0

—

29.8

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

0.00

0.0

1.4

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

0.00

0.0

1.3

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

0.00

0.0

1.0

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

0.00

0.0

2.0

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

0.97

0.00

1.2

1.5

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

0.00

0.0

1.2

—

1.6

—

(3035320) C reactive protein [Mass/volume] in Body fluid

0.00

0.0

1.6

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

0.00

0.0

2.5

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

0.00

0.0

1.4

—

Mortality – FinRegistry

↥

Association

Association between endpoint L12_ERYTHRASMA and mortality.

Females

No data

Males

No data

Mortality risk

Mortality risk for people of age

years, who have L12_ERYTHRASMA.

N-year risk	Females	Males
1	No data	No data
5	No data	No data
10	No data	No data
15	No data	No data
20	No data	No data

Relationships between endpoints

↥

Index endpoint: L12_ERYTHRASMA – Erythrasma

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Erythrasma

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints